FLUENT sells Texas cannabis business to Legacy Therapeutics for $30M to reduce debt.

FLUENT Corp. has agreed to sell its Texas cannabis operations, including licenses and retail locations, to Legacy Therapeutics for $30 million. The deal involves $25 million paid at closing and $2.5 million on each of the next two anniversaries. FLUENT plans to use the proceeds primarily to pay down senior secured debt and support general corporate needs. The transaction awaits regulatory approval and aims to leverage Legacy's pharmaceutical expertise to grow the Texas cannabis market.